| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/14/2007 | US20070135458 6-Substituted pyrido-pyrimidines |
| 06/14/2007 | US20070135386 Novel Compounds and Compositions as Cathepsin Inhibitors |
| 06/14/2007 | US20070134342 Injectable carrier formulations of hyaluronic acid derivatives for delivery of osteogenic proteins |
| 06/14/2007 | US20070134319 Pharmaceutical formulations of bisphosphonates |
| 06/14/2007 | US20070134258 Gasp1: a follistatin domain containing protein |
| 06/14/2007 | US20070134211 Differentiation of adipose stromal cells into osteoblasts and uses thereof |
| 06/14/2007 | US20070134198 Composition and use of RAR antagonists for promoting chondrogenesis |
| 06/14/2007 | CA2631850A1 Equol-containing fermentation product of soybean embryonic axis, and method for production thereof |
| 06/14/2007 | CA2631794A1 P38 kinase inhibiting agents |
| 06/13/2007 | EP1795598A1 Novel peptides |
| 06/13/2007 | EP1795203A2 Fhit proteins and nucleic acids and methods based thereon |
| 06/13/2007 | EP1795192A2 1-Substituted imidazole derivatives as nos inhibitors |
| 06/13/2007 | EP1794160A1 6-(2-alkyl-phenyl) - pyrido[2,3-d] pyrimidines useful as proteine kinase inhibitors |
| 06/13/2007 | EP1793847A2 Use of microproteins as tryptase inhibitors |
| 06/13/2007 | EP1490065B1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors |
| 06/13/2007 | EP1456219B1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist |
| 06/13/2007 | EP1455810B1 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 06/13/2007 | EP1416931B1 Inhibitors of polyq-aggregation |
| 06/13/2007 | EP1408988B1 Compositions of orally administered nutritional supplements to repair articular cartilage |
| 06/13/2007 | EP1339737B1 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2007 | EP1337512B1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists |
| 06/13/2007 | EP1230349B1 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 06/13/2007 | EP1214292B1 Tyrosine derivatives |
| 06/13/2007 | EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/13/2007 | EP1140969B1 Connective tissue growth factor fragments and methods and uses thereof |
| 06/13/2007 | EP0914431B1 Truncated soluble tumor necrosis factor type-i receptors |
| 06/13/2007 | EP0889972B1 Use of the determination of polymorphims in the promoter region of the TGF-beta 1 gene in diagnosis |
| 06/13/2007 | CN1980897A 4-phenyl-pyrimidine-2-carbonitrile derivatives |
| 06/13/2007 | CN1977966A Ointment capable of expelling wind and eliminating stasis |
| 06/13/2007 | CN1977963A External Chinese medicine for treating ankylosing spondylitis |
| 06/13/2007 | CN1977961A Chinese medicine for treating lumhardisc protrusion |
| 06/13/2007 | CN1977934A Medicinal liquor for treating cervix vertebra disease and lumbar disc protrusion and its preparing method |
| 06/13/2007 | CN1977933A Bone-setting medicine and its use method |
| 06/13/2007 | CN1977932A Tiaogu tablet composition and its production process |
| 06/13/2007 | CN1977928A Chinese medicine neck support for treating cervix vertebra disease and its preparing method |
| 06/13/2007 | CN1977923A Chinese medicine composition for treating arthralgia syndrome |
| 06/13/2007 | CN1977899A Medicine for treating rheumatoid arthritis |
| 06/13/2007 | CN1977873A Epimedium total flavone extracting process |
| 06/13/2007 | CN1977842A Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents |
| 06/13/2007 | CN1977837A Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 06/13/2007 | CN1977836A Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 06/13/2007 | CN1977835A Monomer medicine for treating ankylosing spondylitis |
| 06/13/2007 | CN1977814A Plant eye cream function lotion |
| 06/13/2007 | CN1977807A Chinese herbal medicine skin product |
| 06/13/2007 | CN1321129C Inhibitors of caspases |
| 06/13/2007 | CN1320910C Medicine for treating osteoarthritis, and its prepn. method |
| 06/13/2007 | CN1320905C Inflammation-resisting pain-stopping preparation |
| 06/13/2007 | CN1320880C Improved formulation for topical non-invasive application in vivo |
| 06/12/2007 | US7230132 Aryl N-cyanoguanidines and methods related thereto |
| 06/12/2007 | US7230106 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 06/12/2007 | US7230096 derivatives of 3'-amino LacNAc for treatment of inflammation, septic shock, cancer, autoimmune diseases, rheumatoid arthritis and multiple schlerosis |
| 06/12/2007 | US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 06/12/2007 | US7230026 Selected fused pyrrolocarbazoles |
| 06/12/2007 | US7230015 Potassium/sodium channel blockers; for treatment of multiple sclerosis, spinal cord injury, traumatic brain injury, stroke, bladder irritation and dysfunction, neuropathic pain and chemokine-induced pain |
| 06/12/2007 | US7229987 Oxazoles with one or more tertiary amine groups and phenyl groups, e.g., 1-{4-[2-(Benzofuran-2-ylmethoxymethyl)-oxazol-5-yl]-phenyl}-3-(2-dimethylamino-ethyl)-urea and -(3-{4-[2-(2-Phenoxy-ethylsulfanylmethyl)-oxazol-5-yl]-phenoxy}-propyl)-azepine; treating obesity and related diseases, e.g., diabetes |
| 06/12/2007 | US7229962 A fusion protein is dimerized with two soluble extracellular domains of proteins by intermolecular disulfide bonds, formation/s-s/; improved stability and therapeutic effects |
| 06/12/2007 | US7229809 Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases |
| 06/12/2007 | US7229770 YKL-40 as a marker and prognostic indicator for cancers |
| 06/12/2007 | US7229646 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| 06/12/2007 | CA2326510C Dextran formulations and method for treatment of inflammatory joint disorders |
| 06/07/2007 | WO2007064749A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | WO2007064618A1 Methods for the treatment of muscle loss |
| 06/07/2007 | WO2007064304A1 Biocompatible composition and uses thereof |
| 06/07/2007 | WO2007063311A2 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 06/07/2007 | WO2007063308A2 Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 06/07/2007 | WO2007024631A3 Botulinum toxin in treatment of clubfoot |
| 06/07/2007 | WO2007020103A3 Novel use of peptide compounds for treating muscle pain |
| 06/07/2007 | WO2007011232A3 Lipid lowering agents for increasing bmd |
| 06/07/2007 | US20070129426 Therapeutic drugs for arthritis |
| 06/07/2007 | US20070129348 Receptor antagonist |
| 06/07/2007 | US20070129285 Protein a compositions and methods of use |
| 06/07/2007 | US20070128672 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 06/07/2007 | US20070128648 Methods for the Identification of IKKalpha Function and other Genes Useful for Treatment of Inflammatory Diseases |
| 06/07/2007 | US20070128616 Aggrecanase molecules |
| 06/07/2007 | US20070128192 Human antibody molecules for il-13 |
| 06/07/2007 | US20070128177 Methods and compositions for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders |
| 06/07/2007 | US20070128112 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 06/07/2007 | CA2632922A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | CA2632866A1 Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 06/07/2007 | CA2629850A1 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 06/07/2007 | CA2629587A1 Prodrug er.beta.-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds |
| 06/07/2007 | CA2629037A1 Compositions comprising a combination of ccr5 and cxcr4 antagonists |
| 06/06/2007 | EP1792983A1 Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiences thereof |
| 06/06/2007 | EP1792977A1 Medium for the redifferentiation of dedifferentiated chondrocytes into chondrocytes |
| 06/06/2007 | EP1792910A2 Effectors of dipeptidyl peptidase IV for topical use |
| 06/06/2007 | EP1791552A2 Protein a compositions and methods of use |
| 06/06/2007 | EP1496894A4 Angiogenesis inhibitors |
| 06/06/2007 | EP1489083B1 Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 06/06/2007 | EP1406660B1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor |
| 06/06/2007 | EP1363874B1 Tryptase inhibitors |
| 06/06/2007 | EP1181056B1 Lim mineralization protein splice variants |
| 06/06/2007 | EP1158958B1 Improved powdery pharmaceutical compositions for inhalation |
| 06/06/2007 | EP0954317B1 Use of 7 apha-substituted steroids to treat neuropsychiatric disorders |
| 06/06/2007 | CN2907589Y Electric heating plaster contg. traditional Chinese medicine |
| 06/06/2007 | CN1976908A Method for preparing 5-[4-(2-hydroxy-ethyl)-3,5-dioxo-4,5-dihydro-3H-[1,2,4]-triazin-2-yl]benzamide derivatives with P 2 X 7 inhibiting activity by reaction of the derivative unsubstituted in 4-positi |
| 06/06/2007 | CN1976726A Compositions and methods for modulating bone mass |
| 06/06/2007 | CN1976690A Pharmaceutical compositions for the treatment of disease and/or symptoms in arthritis |
| 06/06/2007 | CN1974574A Novel tricyclic spiropiperidines or spiropyrrolidines |
| 06/06/2007 | CN1973893A Externally applied medicine for treating neck and waist arthrosis |
| 06/06/2007 | CN1973882A Pain-relieving plaster and its prepn |